Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Accelerated humoral renal allograft rejection due to HLA-C14 mediated allosensitization to HLA-Bw6.

Persaud SP, Duffy B, Phelan DL, Mohanakumar T, Delos Santos R, Gaut JP, Liu C.

Hum Immunol. 2017 Nov;78(11-12):692-698. doi: 10.1016/j.humimm.2017.09.004. Epub 2017 Oct 9.

PMID:
29024716
2.

Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation.

Liu C, Wetter L, Pang S, Phelan DL, Mohanakumar T, Morris GP.

Hum Immunol. 2012 Jun;73(6):597-604. doi: 10.1016/j.humimm.2012.04.016. Epub 2012 Apr 23.

PMID:
22537756
3.

CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study.

Lawrence KL, White PH, Morris GP, Jennemann J, Phelan DL, Hotchkiss RS, Kollef MH.

Crit Care. 2010;14(3):R110. doi: 10.1186/cc9059. Epub 2010 Jun 11.

4.

Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.

Morris GP, Phelan DL, Jendrisak MD, Mohanakumar T.

Hum Immunol. 2010 Mar;71(3):268-73. doi: 10.1016/j.humimm.2010.01.003. Epub 2010 Jan 25.

PMID:
20074605
5.

A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption.

Scope A, Lieb JA, Dusza SW, Phelan DL, Myskowski PL, Saltz L, Halpern AC.

J Am Acad Dermatol. 2009 Oct;61(4):614-20. doi: 10.1016/j.jaad.2009.03.046. Epub 2009 Jul 31.

PMID:
19646778
6.

A survey of skin cancer screening practices among dermatology nurses.

Phelan DL, Heneghan M.

Dermatol Nurs. 2008 Oct;20(5):357-64.

PMID:
19051782
7.

Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.

Holt DB, Lublin DM, Phelan DL, Boslaugh SE, Gandhi SK, Huddleston CB, Saffitz JE, Canter CE.

J Heart Lung Transplant. 2007 Sep;26(9):876-82.

PMID:
17845925
8.

A significant role for histocompatibility in human islet transplantation.

Mohanakumar T, Narayanan K, Desai N, Ramachandran S, Shenoy S, Jendrisak M, Susskind BM, Olack B, Benshoff N, Phelan DL, Brennan DC, Fernandez LA, Odorico JS, Polonsky KS.

Transplantation. 2006 Jul 27;82(2):180-7.

PMID:
16858280
9.

Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma.

Hay JL, Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Halpern AC.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1212-6.

10.

HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.

Narayanan K, Jendrisak MD, Phelan DL, Mohanakumar T.

Transpl Immunol. 2006 Jan;15(3):187-97. Epub 2005 Oct 6.

PMID:
16431285
11.

Patient experiences with photo books in monthly skin self-examinations.

Phelan DL, Oliveria SA, Halpern AC.

Dermatol Nurs. 2005 Apr;17(2):109-14.

PMID:
15916185
13.

Patient adherence to skin self-examination. effect of nurse intervention with photographs.

Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC.

Am J Prev Med. 2004 Feb;26(2):152-5.

PMID:
14751328
14.

Skin self-examination in patients at high risk for melanoma: a pilot study.

Phelan DL, Oliveria SA, Christos PJ, Dusza SW, Halpern AC.

Oncol Nurs Forum. 2003 Nov-Dec;30(6):1029-36.

PMID:
14603360
15.

Association of the HLA-DR15/HLA-DQ6 haplotype with development of choroidal neovascular lesions in presumed ocular histoplasmosis syndrome.

Dabil H, Kaplan HJ, Duffy BF, Phelan DL, Mohanakumar T, Jaramillo A.

Hum Immunol. 2003 Oct;64(10):960-4.

PMID:
14522093
16.

Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.

Smith MA, Sundaresan S, Mohanakumar T, Trulock EP, Lynch JP, Phelan DL, Cooper JD, Patterson GA.

J Thorac Cardiovasc Surg. 1998 Nov;116(5):812-20.

17.

Cytomegalovirus and HLA-A, B, and DR locus interactions: impact on renal transplant graft survival.

Schnitzler MA, Woodward RS, Brennan DC, Phelan DL, Spitznagel EL, Boxerman SB, Dunagan WC, Bailey TC.

Am J Kidney Dis. 1997 Dec;30(6):766-71.

PMID:
9398119
18.

HLA typing in women with and without silicone gel-filled breast implants.

Young VL, Nemecek JR, Schwartz BD, Phelan DL, Schorr MW.

Curr Top Microbiol Immunol. 1996;210:209-25. No abstract available.

PMID:
8565559
19.

HLA typing in women with breast implants.

Young VL, Nemecek JR, Schwartz BD, Phelan DL, Schorr MW.

Plast Reconstr Surg. 1995 Dec;96(7):1497-519; discussion 1520.

PMID:
7480270
20.

FK506--reversal of humorally mediated cardiac allograft rejection in the presence of preformed anti-class I antibody.

Woodle ES, Phelan DL, Saffitz JE, Mohanakumar T, Shenoy S, Pasque M.

Transplantation. 1993 Nov;56(5):1271-5. No abstract available.

PMID:
7504346
21.

Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation.

Chauhan B, Phelan DL, Marsh JW, Mohanakumar T.

Transplantation. 1993 Aug;56(2):443-8.

PMID:
7689260
22.

Recombinant erythropoietin: does it really effect sensitization?

Phelan DL, Hibbett S, Wetter L, Hanto DW, Mohanakumar T.

Transplant Proc. 1991 Feb;23(1 Pt 1):409-10. No abstract available.

PMID:
1990569
23.

Multiparous women: is routine antibody screening enough in cardiac transplantation?

Miller LW, Phelan DL, Noedel N, McBride LR, Pennington DG.

Transplant Proc. 1991 Feb;23(1 Pt 2):1135-6. No abstract available.

PMID:
1989169
24.

Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient.

Flye MW, Duffy BF, Phelan DL, Ratner LE, Mohanakumar T.

Transplantation. 1990 Dec;50(6):1051-4. No abstract available.

PMID:
2256146
26.
27.

Positive B cell crossmatches: specificity of antibody and graft outcome.

Phelan DL, Rodey GE, Flye MW, Hanto DW, Anderson CB, Mohanakumar T.

Transplant Proc. 1989 Feb;21(1 Pt 1):687-8. No abstract available.

PMID:
2650222
28.

Prediction of crossmatch outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies.

Oldfather JW, Anderson CB, Phelan DL, Cross DE, Luger AM, Rodey GE.

Transplantation. 1986 Sep;42(3):267-70.

PMID:
3529527

Supplemental Content

Loading ...
Support Center